Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Axcan launches mesalamine suppositories in U.S. for active ulcerative proctitis

April 20, 2001

Pharmacological characterization of the potential new prokinetic drug KF-66854

April 19, 2001

Novel antioxidant A-2757 effective in animal models of hepatic and renal injury

April 19, 2001

The future role of rabeprazole in the treatment of acid-related disorders

April 17, 2001

Maxim's Ceplene to be included in DITTO-HCV study

April 17, 2001

Study demonstrates Origenix compounds effective against HBV replication

April 12, 2001

Expanded access program brings PEGASYS to hepatitis patients in Canada

April 11, 2001

New class of compounds found active against hepatitis C

April 9, 2001

Italian researchers identify new indazolamides with utility particularly in IBS

April 6, 2001

Novel naturally produced compound is selective against H. pylori

April 5, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...